BS OR 011
Alternative Names: BS-OR-011Latest Information Update: 28 Jan 2019
At a glance
- Originator Hangzhou Bensheng Pharmaceutical
- Class Antineoplastics; Diterpenes; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer; Colorectal cancer; Oesophageal cancer
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for research development in Breast-cancer in China
- 28 Jan 2019 No recent reports of development identified for research development in Colorectal-cancer in China
- 28 Jan 2019 No recent reports of development identified for research development in Oesophageal-cancer in China